Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondria and neuroprotective pathways refer to the integrated biological systems that maintain mitochondrial integrity to protect neurons from injury and death (Lin & Beal, 2006). Mitochondria are central to cellular energy metabolism, calcium signaling, and the initiation of apoptosis, making them critical determinants of neuronal survival (Murphy & Hartley, 2018). Dysfunction in these pathways, characterized by oxidative stress and impaired ATP production, is a primary driver of neurodegenerative disorders such as Parkinson's and Alzheimer's disease (Bhatia et al., 2022). Therapeutic approaches targeting these pathways involve the use of antioxidants, mitochondrial membrane stabilizers, and metabolic enhancers like Elamipretide or MitoQ (ClinicalTrials.gov). While not a single molecular target, this category encompasses a variety of specific proteins and enzymes involved in mitochondrial quality control and bioenergetics. These pathways are essential for maintaining the high energy demands of neurons and preventing the release of pro-apoptotic factors like cytochrome c. Research in this area often focuses on the PGC-1alpha/SIRT1 axis to promote mitochondrial biogenesis as a neuroprotective strategy. Overall, modulating these pathways represents a significant frontier in treating chronic neurological conditions.
Enhancement of mitochondrial bioenergetics, reduction of reactive oxygen species (ROS) production, and stabilization of the mitochondrial membrane to prevent the activation of neuronal cell death cascades.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondria and neuroprotective pathways.